News
Search and Filter
Results per Page:
Fred Hutch President and Director Dr. Gary Gilliland announces plan to step down
5 years of leadership reinforced Fred Hutch scientific excellence, collaborative research, partnerships and financial strength
Two Irish microbiologists find their way, together, to Seattle
Microbiome experts Drs. Susan Bullman and Christopher Johnston join Fred Hutch
Drs. Jeanne Ting Chowning, Denise Galloway receive Seattle AWIS awards
Honored for excellence in STEM education/outreach, science advancement and leadership
Drs. Denise Galloway and Hans-Peter Kiem receive endowed chairs
Paul Stephanus Memorial Endowed Chair to Galloway; Stephanus Family Endowed Chair for Cell and Gene Therapy to Kiem
Exploring why people with HIV have a higher lung cancer risk
120 volunteers to enroll in Seattle-area study of cancer-related gene mutations
H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer
Galloway and Hartwell to enter Washington Life Science Hall of Fame
Awards recognize power of basic research, leadership in driving advances for patients
Jump-starting innovative projects exploring pathogen-associated cancers
Pathogen-Associated Malignancies Integrated Research Center awards first round of pilot funding supporting researchers studying H. pylori, EBV and the microbiome
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Good News: Purchase Fred Hutch vanity plates to help drive cancer research
Celebrating faculty and staff achievements
Galloway receives NCI Outstanding Investigator Award
Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Triple therapy for rare skin cancer shows promise in small, early-stage trial
Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
What we’re learning about cancer-causing bacteria and viruses
Unusual links between our microbiome and cancer highlighted at 2017 American Society of Preventive Oncology
‘It’s been an incredible ride’
Dr. Denise Galloway reflects on a career — and a life — touched by cancer